Cargando…

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

The increasing knowledge on inflammatory pathways has driven the development of targeted biological therapies for severe refractory asthma. Among the recently developed biologics, the fully human monoclonal antibody dupilumab is an interesting therapeutic option, given its ability to inhibit the bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzella, Francesco, Montanari, Gloria, Patricelli, Giulia, Cavazza, Alberto, Galeone, Carla, Ruggiero, Patrizia, Bagnasco, Diego, Facciolongo, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636310/ https://www.ncbi.nlm.nih.gov/pubmed/31371974 http://dx.doi.org/10.2147/TCRM.S207402

Ejemplares similares

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Heat-induced necrosis after bronchial thermoplasty: a new concern?
por: Menzella, Francesco, et al.
Publicado: (2018)

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
por: Menzella, Francesco, et al.
Publicado: (2019)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

The clinical profile of benralizumab in the management of severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Eosinophilic infiltrate in a patient with severe Legionella pneumonia as a levofloxacin-related complication: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2010)

The pharmacoeconomics of the state-of-the-art drug treatments for asthma: a systematic review
por: Menzella, Francesco, et al.
Publicado: (2021)

Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance
por: Scelfo, Chiara, et al.
Publicado: (2021)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
por: Menzella, Francesco, et al.
Publicado: (2017)

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?
por: Galeone, Carla, et al.
Publicado: (2018)

Towards precision medicine: The application of omics technologies in asthma management
por: Scelfo, Chiara, et al.
Publicado: (2018)

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?
por: Menzella, Francesco, et al.
Publicado: (2017)

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
por: Menzella, Francesco, et al.
Publicado: (2017)

Immunological Aspects Related to Viral Infections in Severe Asthma and the Role of Omalizumab
por: Menzella, Francesco, et al.
Publicado: (2021)

Bronchial thermoplasty in severe asthma: a real-world study on efficacy and gene profiling
por: Facciolongo, Nicola, et al.
Publicado: (2022)

Real world effectiveness of benralizumab on respiratory function and asthma control
por: Menzella, Francesco, et al.
Publicado: (2021)

May 2020: Is It Always COVID-19 No Matter What?
por: Livrieri, Francesco, et al.
Publicado: (2020)

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report
por: Facciolongo, Nicola, et al.
Publicado: (2015)

Efficacy and safety of EBUS‐TBNA under conscious sedation with meperidine and midazolam
por: Piro, Roberto, et al.
Publicado: (2022)

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report
por: Menzella, Francesco, et al.
Publicado: (2018)

How Can Dupilumab Cause Eosinophilic Pneumonia?
por: Kurihara, Momoko, et al.
Publicado: (2022)

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life
por: Menzella, Francesco, et al.
Publicado: (2022)

A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM)
por: Menzella, Francesco, et al.
Publicado: (2021)

“Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report”
por: Carbonelli, Cristiano, et al.
Publicado: (2012)

Eosinophilic Gastritis in a Patient Previously Treated with Dupilumab
por: Iwamuro, Masaya, et al.
Publicado: (2020)

Refractory Pediatric Fibrostenotic Eosinophilic Esophagitis Treated With Dupilumab
por: Gangadharan Nambiar, Gopinathan, et al.
Publicado: (2022)

Relapse of Eosinophilic Esophagitis on Dupilumab
por: Buendia, Matthew A., et al.
Publicado: (2022)

Real-life Efficacy of Omalizumab After 9 Years of Follow-up
por: Menzella, Francesco, et al.
Publicado: (2017)

Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab
por: Ledda, Andrea Giovanni, et al.
Publicado: (2023)

Eosinophilic pneumonia developed after dupilumab administration in a patient with atopic dermatitis
por: Kanata, Kei, et al.
Publicado: (2023)

Dupilumab-Associated Eosinophilic Granulomatosis With Polyangiitis
por: Persaud, Purnadeo, et al.
Publicado: (2022)

Eosinophilic granulomatosis with polyangiitis after treatment with dupilumab
por: Yamazaki, Kai, et al.
Publicado: (2022)

Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
por: Menzella, Francesco, et al.
Publicado: (2020)

A Dangerous Consequence of the Recent Pandemic: Early Lung Fibrosis Following COVID-19 Pneumonia – Case Reports
por: Scelfo, Chiara, et al.
Publicado: (2020)

Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020)

Tailored therapy for severe asthma
por: Menzella, Francesco, et al.
Publicado: (2015)

Ophiasis treated with dupilumab
por: Abercrombie, McKenna, et al.
Publicado: (2021)

Targeting eosinophils: severe asthma and beyond
por: Caminati, Marco, et al.
Publicado: (2019)

Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report
por: Suzaki, Isao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jrv8gr6ui6krl58o492jm28vvs